Sun Pharmaceutical Industries Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Bonus
• Share holding
• Capital structures
• Ratio

Sep ' 23	Sep ' 22	Mar ' 22	Sep ' 21	Sep ' 20

Sales

9,562.28

10,218.17

7,777.54

7,808.44

6,255.55

Operating profit

2,335.08

3,112.83

1,656.23

1,251.29

1,509.51

Interest

351.57

179.84

176.66

211.44

82.32

Gross profit

2,253.59

3,023.69

2,085.21

1,392.13

1,521.56

EPS (Rs)

5.29

9.27

-3.21

2.80

5.24

Other income

270.08

90.70

605.64

352.28

94.37

Stock adjustment

81.16

-95.63

-175.23

-7.95

-150.76

Raw material

2,251.87

2,727.01

2,413.29

2,171.68

1,852.14

Power and fuel

-

-

-

-

-

Employee expenses

1,207.85

1,101.66

999.73

1,001.05

918.35

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

3,686.32

3,372.30

2,883.52

3,392.37

2,126.31

Provisions made

-

-

-

-

-

Depreciation

807.98

758.45

709.38

640.57

288.16

Taxation

27.13

40.43

491.65

-84.80

-23.36

Net profit / loss

1,269.27

2,224.81

-770.78

670.79

1,256.76

Extra ordinary item

-149.21

-

-1,654.96

-165.57

-

Prior year adjustments

-

-

-

-

-

Equity capital

239.93

239.93

239.93

239.93

239.93

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

24.42

30.46

21.30

16.02

24.13

GPM (%)

22.92

29.33

24.87

17.06

23.96

NPM (%)

12.91

21.58

-9.19

8.22

19.79